# fibrosis (blogs) — RSS Amplifier Recent posts from the 2 feeds in the RSS Amplifier directory that cover fibrosis. Page: Feed: --- ## [Study links new cell type to lung scarring in pulmonary fibrosis patients](https://pulmonaryfibrosisnews.com/news/study-links-new-cell-type-lung-scarring-pf-patients/) _2026-08-19 · Andrea Lobo · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ A new type of pericyte called Peri2 is linked to scar tissue formation in the lungs of people with pulmonary fibrosis (PF), according to a study. Pericytes are cells that surround blood vessels. A gene called FOXF1 was also shown to help control whether these cells stay healthy or switch into a damaging, fibrosis-driving state. \[…\] The post Study links new cell type to lung scarring in pulmonary… ## [Recent health setbacks require us to find a more accessible home](https://pulmonaryfibrosisnews.com/columns/recent-health-setbacks-require-us-find-accessible-home/) _2026-08-18 · Samuel Kirton · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ In case you hadn’t noticed, I didn’t file a column last week. I missed you and feel like I need to explain. My body told me I needed to take a break. I had back-to-back medical appointments that left me wiped out, so I decided to listen to my body. Little did I know at \[…\] The post Recent health setbacks require us to find a more accessible home appeared first on Pulmonary Fibrosis News . ## [First global trial now testing new treatment for chronic cough in IPF](https://pulmonaryfibrosisnews.com/news/first-global-trial-now-testing-new-treatment-chronic-cough-ipf/) _2026-08-12 · Michela Luciano, PhD · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ According to its U.S. developer, the first of two global clinical trials designed to test Haduvio (nalbuphine extended-release) — a potential treatment for chronic cough due to idiopathic pulmonary fibrosis (IPF) — is now underway, with the second expected to launch later this year. The initial Phase 3 trial, dubbed OCEAN-1 (NCT07671911), is evaluating the \[…\] The post First global trial now… ## [Panacell Biotech Files Patent Application for Novel "3-Month Room-Temperature Storage" Exosome Technology](https://www.sisunnews.co.kr/news/articleView.html?idxno=244153) _2026-08-12 · easyaan@sisunnews.co.kr (이지안) · 시선뉴스 - NOW_ Domestic advanced biotech company Panacell Biotech (CEO Choi Seung-ho) announced that it has successfully developed proprietary source technology capable of stably storing exosomes at room temperature (15-25 C) for up to three months, and has completed both domestic and international patent filings for the innovation. Exosomes are nano-sized particles responsible for cell-to-cell signal… ## [Inhaled IPF therapy moves to Phase 2 as early trial shows promise](https://pulmonaryfibrosisnews.com/news/inhaled-ipf-therapy-moves-phase-2-early-trial-shows-promise/) _2026-08-05 · Marisa Horak, MS · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ The inhaled therapy MNKD-201 was tolerated well in people with idiopathic pulmonary fibrosis (IPF) in a Phase 1 clinical trial, and a Phase 2 study to further test it is underway, the treatment’s developer said. The Phase 2 trial, INFLO-2 (NCT07679893), aims to enroll more than 200 adults with IPF, ages 40 to 80, who \[…\] The post Inhaled IPF therapy moves to Phase 2 as early trial shows promise… ## [Hopeful about the growing interest in IPF research and investment](https://pulmonaryfibrosisnews.com/columns/hopeful-about-growing-interest-ipf-research-investment/) _2026-08-04 · Samuel Kirton · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ Idiopathic pulmonary fibrosis (IPF) is emerging as a “hot spot” for drug development research, according to the nonprofit CheckOrphan, which notes that “investor and industry interest is accelerating.” A May 2026 article on the organization’s website notes recent activity by Avalyn Pharma, which has secured $100 million in research funding, along with recent moves by \[…\] The post Hopeful about the… ## [Managing the medical costs associated with chronic illness](https://pulmonaryfibrosisnews.com/columns/managing-medical-costs-associated-chronic-illness/) _2026-07-30 · Kylene Henderson · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ Up until my husband, Donnie, became ill with pulmonary fibrosis, our family had been relatively healthy and free of any major issues. Each of us made it to our annual checkups, plus an additional appointment or two during cold and flu season. We probably had a handful of prescriptions between the four of us, and \[…\] The post Managing the medical costs associated with chronic illness appeared first… ## [Participants sought for global clinical trial testing inhaled IPF therapy](https://pulmonaryfibrosisnews.com/news/global-clinical-trial-testing-inhaled-ipf-therapy-now-enrolling-all-sites/) _2026-07-29 · Marisa Horak, MS · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ An international clinical trial testing LTI-03, Rein Therapeutics’ inhaled treatment candidate for idiopathic pulmonary fibrosis (IPF), is now recruiting participants at sites in five countries. The Phase 2 trial, dubbed RENEW (NCT06968845), aims to enroll approximately 120 people with IPF, ages 40 and older. Eligible participants will have been diagnosed within the last five years \[…\] The post… ## [Post-hospitalization rehabilitation and recovery have been hard](https://pulmonaryfibrosisnews.com/columns/post-hospitalization-rehabilitation-recovery-hard/) _2026-07-28 · Samuel Kirton · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ Rehabilitation from serious health setbacks is hard. This week has repeatedly proven that to me. Since being diagnosed with idiopathic pulmonary fibrosis (IPF) in January 2017, I’ve learned a lot about the disease. But I haven’t learned everything yet. During my IPF journey, I wasn’t hospitalized after my diagnosis until I received a bilateral lung \[…\] The post Post-hospitalization rehabilitation… ## [Panacell Biotech Earns ISO 9001 Certification, Strengthening Global Quality Standards for Pulmonary Fibrosis Therapy Development](https://www.sisunnews.co.kr/news/articleView.html?idxno=243016) _2026-07-24 · easyaan@sisunnews.co.kr (이지안) · 시선뉴스 - NOW_ Panacell Biotech Earns ISO 9001 Certification, Strengthening Global Quality Standards for Pulmonary Fibrosis Therapy Development Panacell Biotech, a company at the forefront of innovation in advanced regenerative medicine and cell therapy, announced that it has obtained ISO 9001, the internationally recognized quality management system (QMS) certification established by the International… ## [Anthony Ettinger on LinkedIn (Sponsored)](https://crawlproof.com/a/rOZqI3R7gqIT) _2026-07-24 · **Sponsored**_ Public LinkedIn profile at linkedin.com/in/anthonyettinger. ## [EU approves Jascayd as first new IPF oral treatment in a decade](https://pulmonaryfibrosisnews.com/news/eu-approves-jascayd-first-new-ipf-oral-treatment-decade/) _2026-07-22 · Marisa Horak, MS · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ The oral therapy Jascayd (nerandomilast) has been approved in the European Union for adults with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). The marketing authorization from the European Commission follows a positive recommendation from a regulatory committee and marks the first new IPF therapy approved in the EU in more than a decade, \[…\] The post EU approves… ## [Life on the farm looks different with pulmonary fibrosis](https://pulmonaryfibrosisnews.com/columns/the-life-my-hands-once-i-knew-living-with-pulmonary-fibrosis/) _2026-07-21 · Ann Reynoso · Pulmonary Fibrosis News – The Web's Daily Resource for PF News_ When my husband and I decided to move to a small farm, we imagined early mornings feeding chickens, tending the garden together, and watching cattle graze in the distance. It wasn’t simply a place to live. It was the life we had dreamed of building. No one imagines that one day their own body will become the biggest obstacle to living \[…\] The post Life on the farm looks different with pulmonary… ## [Panacell Biotech Reports Preclinical Success of Exosome Regenerative Therapy Platform for Pulmonary Fibrosis](https://www.sisunnews.co.kr/news/articleView.html?idxno=236452) _2026-04-06 · sisunnews@sisunnews.co.kr (Jeong-in Choi) · 시선뉴스 - NOW_ Source: Panacell Biotech Pulmonary fibrosis is a devastating disease affecting over 10% of the population aged 50 and older, with a five-year survival rate reported to be below 40%. In the United States alone, approximately 30,000 patients die from the condition annually-a figure comparable to the annual mortality rate of breast cancer. Panacell Biotech (CEO Choi Seung Ho) announced that its… ## [\[Interview 360\] Why Security Vendors Are Rewriting Their Playbooks for the Cloud Era](https://www.sisunnews.co.kr/news/articleView.html?idxno=234571) _2026-02-13 · bmw8234@sisunnews.co.kr (심재민 기자) · 시선뉴스 - NOW_ As cloud adoption accelerates, security standards are evolving just as quickly. The industry's focus is shifting away from server-based intrusion prevention toward identifying risks tied to user accounts and behavioral patterns. In turn, security solutions are changing as well - no longer limited to on-premise installations, but increasingly built to function across both on-premise and cloud… ## [\[Interview 360\] From Communication to Accountability: How LARS Is Shaping the Technology of Post-Disaster Response](https://www.sisunnews.co.kr/news/articleView.html?idxno=233995) _2026-01-29 · bmw8234@sisunnews.co.kr (심재민 기자) · 시선뉴스 - NOW_ Disasters strike without warning. Wildfires, floods, structural collapses, and large-scale accidents vary widely in type and scale, but they all share one common starting point: communication. Just as critical is the record of how that communication unfolded-documentation that makes accountability and systemic improvement possible after the fact. This is where the PS-LTE-based public safety… ## [\[Interview 360\] Setting a New Standard for Corporate Data Leakage Management in the Age of Generative AI: XCURENET EMASS AI·AI PLUS](https://www.sisunnews.co.kr/news/articleView.html?idxno=233476) _2026-01-15 · bmw8234@sisunnews.co.kr (심재민 기자) · 시선뉴스 - NOW_ The rapid spread of generative AI is transforming corporate work environments at unprecedented speed. Tasks once confined to internal systems-such as source code summarization, design analysis, and meeting minutes-are increasingly handled through external AI services, delivering clear productivity gains. At the same time, organizations are finding it more difficult to maintain visibility and… ## [自民党、国民民主党に連立参加を相次ぎ打診](https://www.sisunnews.co.kr/news/articleView.html?idxno=233202) _2026-01-07 · bmw8234@sisunnews.co.kr (심재민 기자) · 시선뉴스 - NOW_ 高市早苗首相と玉木雄一郎・国民民主党代表［共同・聯合ニュース資料写真。再販売およびデータベース（DB）への使用禁止］ 日本の与党・自由民主党が、第二野党の国民民主党に対し、連立政権への参加を視野に入れた協力要請を相次いで示している。政権運営の安定化を図る狙いがあるとみられ、政界では連立拡大の可能性を含め、今後の動向に注目が集まっている。 スズキ俊一自民党幹事長は記者会見で、あくまで個人的な見解としたうえで、「三党連立という形になれば、政治の安定がより確かなものになる」と述べた。これは、自民党と日本維新の会による連立政権に国民民主党が加わる構図を念頭に置いた発言と受け止められている。… ## [\[Interview360\] XCURENET on Moving Beyond Intrusion Prevention to Predictive Security](https://www.sisunnews.co.kr/news/articleView.html?idxno=233012) _2025-12-31 · bmw8234@sisunnews.co.kr (심재민 기자) · 시선뉴스 - NOW_ As high-profile security incidents continue to recur, the public conversation is shifting from the question of whether systems can block intrusions to whether organizations can anticipate risk, prevent incidents, and sustain security operations over time. Repeated breaches have exposed not only technical weaknesses, but also gaps in day-to-day governance-how security is deployed, maintained, and… ## [REVMED Wins 2025 Korea Trusted Innovation Award for Technological Excellence](https://www.sisunnews.co.kr/news/articleView.html?idxno=231102) _2025-11-11 · sisunnnews@sisunnews.co.kr (류지연) · 시선뉴스 - NOW_ South Korean biomedical company REV-MED Co., Ltd. (CEO Shin Bong-geun) has been honored with the Next-Generation Regenerative Medicine Technology Innovation Award at the 2025 Korea Trusted Innovation Awards, jointly hosted by JoongAng Ilbo and Forbes Korea. The recognition highlights REV-MED's efforts to address long-standing challenges in regenerative medicine-namely, inconsistencies in clinical… ## [Finnish Seedboxes — Up to 20Gbps (Sponsored)](https://crawlproof.com/a/oV4qkg8wrjEM) _2025-11-11 · **Sponsored**_ Private Finnish seedboxes with 1–20Gbps speeds, RAID storage and 14‑day refund ## [Global Celebrities Turn to K-Beauty\_Emerging as a New Wave of Hallyu \[Lifestyle & Health\]](https://www.sisunnews.co.kr/news/articleView.html?idxno=230693) _2025-10-30 · sisunnnews@sisunnews.co.kr (류지연) · 시선뉴스 - NOW_ American celebrity Kim Kardashian (45), who boasts more than 300 million followers worldwide, recently visited South Korea with her sister Khlo Kardashian, sharing their experiences of Korean food, fashion, and beauty procedures. Their visit quickly went viral across social media, once again underscoring the global fascination with K-beauty. Among international visitors, a new trend known as the…